Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 14/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 13/20 | 0.55 |
| ▸ | ACE | P12821 | 13/20 | 0.55 |
| ▸ | CPA1 | P15085 | 11/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31094623 | 0.94 | MME (0.49) | MMEACE2ACECPA1 | |
| SCHEMBL31474490 | 0.91 | MME (0.52) | MMEACE2ACECPA1 | |
| SCHEMBL31195269 | 0.89 | MME (0.50) | MMEACE2ACECPA1 | |
| SCHEMBL30400950 | 0.89 | MME (0.53) | MMEACE2ACECPA1 | |
| SCHEMBL31500682 | 0.88 | ENPEP (0.54) | MMEACE2ACECPA1 | |
| SCHEMBL29860725 | 0.88 | OPRM1 (0.53) | MMEACE | |
| SCHEMBL29860229 | 0.87 | MME (0.47) | MME | |
| SCHEMBL30343610 | 0.86 | NAALAD2 (0.54) | MMEACE2ACECPA1 | |
| SCHEMBL30785953 | 0.86 | OPRM1 (0.56) | MMEACE2ACECPA1 | |
| SCHEMBL30810245 | 0.85 | OPRD1 (0.63) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240254186-A1 | GLP-1 Receptor Agonists Having Improved Pharmacological and Drug Delivery Properties | DARBIX LLC | 2024-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240254186-A1 | GLP-1 Receptor Agonists Having Improved Pharmacological and Drug Delivery Properties | GLP1R, GIPR, IAPP | MME 979/4885ACE2 1955/4885ACE 1591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.